Schizoaffective Disorders Completed Phase 2 Trials for Lurasidone (DB08815)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01731119Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsTreatment